Total Payments
$312,833
2024 Payments
$12,627
Companies
23
Transactions
419
Medicare Patients
7,547
Medicare Billing
$5.1M
Payment Breakdown by Category
Other$194,330 (62.1%)
Consulting$98,600 (31.5%)
Travel$9,028 (2.9%)
Food & Beverage$8,892 (2.8%)
Research$1,200 (0.4%)
Education$783.39 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $194,330 | 120 | 62.1% |
| Consulting Fee | $98,600 | 18 | 31.5% |
| Travel and Lodging | $9,028 | 26 | 2.9% |
| Food and Beverage | $8,892 | 238 | 2.8% |
| Unspecified | $1,200 | 2 | 0.4% |
| Education | $783.39 | 15 | 0.3% |
Payments by Type
General
$311,633
417 transactions
Research
$1,200
1 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Rheumatology | $90,500 | 14 | $0 (2021) |
| Amgen Inc. | $89,802 | 111 | $0 (2024) |
| ABBVIE INC. | $56,213 | 153 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $51,088 | 51 | $0 (2021) |
| Genentech USA, Inc. | $15,376 | 16 | $0 (2019) |
| Lilly USA, LLC | $8,125 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $379.67 | 20 | $0 (2024) |
| Johnson & Johnson Health Care Systems Inc. | $221.09 | 2 | $0 (2022) |
| Genentech, Inc. | $190.00 | 5 | $0 (2018) |
| Horizon Therapeutics plc | $152.04 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,627 | 47 | Amgen Inc. ($6,560) |
| 2023 | $15,487 | 36 | ABBVIE INC. ($10,221) |
| 2022 | $7,466 | 31 | Amgen Inc. ($6,951) |
| 2021 | $18,954 | 38 | United Rheumatology ($7,500) |
| 2020 | $52,056 | 25 | United Rheumatology ($35,000) |
| 2019 | $72,971 | 90 | Amgen Inc. ($30,460) |
| 2018 | $75,720 | 73 | United Rheumatology ($27,500) |
| 2017 | $57,550 | 79 | Amgen Inc. ($24,381) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| 12/20/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.99 | General |
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $112.46 | General |
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Bone Health | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Dermatology | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Bone Health | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Immunology | ||||||
| 07/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Immunology | ||||||
| 07/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Rare Disease | ||||||
| 06/11/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Bone Health | ||||||
| 06/05/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Bone Health | ||||||
| 05/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,813 | 87,641 | $2.0M | $1.2M |
| 2022 | 28 | 1,879 | 110,766 | $2.8M | $1.3M |
| 2021 | 28 | 1,911 | 103,871 | $2.8M | $1.3M |
| 2020 | 30 | 1,944 | 87,337 | $2.7M | $1.3M |
Total Patients
7,547
Total Services
389,615
Medicare Billing
$5.1M
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 135 | 12,300 | $369,000 | $225,830 | 61.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 33 | 6,525 | $371,925 | $220,117 | 59.2% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 45 | 16,250 | $292,500 | $171,823 | 58.7% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 52 | 5,680 | $255,600 | $141,595 | 55.4% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 16 | 22,080 | $176,640 | $103,130 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 449 | 854 | $153,170 | $86,223 | 56.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 22 | 18,200 | $127,400 | $71,459 | 56.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 151 | 312 | $59,554 | $32,725 | 54.9% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 12 | 3,408 | $51,120 | $31,928 | 62.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 165 | 315 | $32,760 | $19,321 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $20,508 | $11,660 | 56.9% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 13 | 25 | $16,825 | $10,146 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 154 | $19,540 | $9,549 | 48.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 82 | 127 | $15,660 | $7,966 | 50.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 31 | 50 | $8,540 | $4,716 | 55.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $8,127 | $4,592 | 56.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 57 | 105 | $5,250 | $2,442 | 46.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 33 | 33 | $3,291 | $1,733 | 52.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 21 | 21 | $1,890 | $1,516 | 80.2% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 18 | 36 | $2,120 | $1,213 | 57.2% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 16 | 25 | $6,250 | $1,127 | 18.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 29 | 145 | $2,030 | $918.09 | 45.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 91 | 768 | $1,344 | $631.62 | 47.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 37 | $925.00 | $385.02 | 41.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 51 | 59 | $354.00 | $335.16 | 94.7% |
About Dr. Adrienne Hollander, M.D
Dr. Adrienne Hollander, M.D is a Rheumatology healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417994633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrienne Hollander, M.D has received a total of $312,833 in payments from pharmaceutical and medical device companies, with $12,627 received in 2024. These payments were reported across 419 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($194,330).
As a Medicare-enrolled provider, Hollander has provided services to 7,547 Medicare beneficiaries, totaling 389,615 services with total Medicare billing of $5.1M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Voorhees, NJ
- Active Since 05/31/2006
- Last Updated 05/16/2018
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1417994633
Products in Payments
- Prolia (Biological) $50,479
- EVENITY (Biological) $38,480
- STELARA (Biological) $27,562
- SIMPONI ARIA (Biological) $19,123
- Actemra (Biological) $15,493
- Rinvoq (Biological) $8,360
- TALTZ (Drug) $6,967
- TREMFYA (Drug) $5,004
- RINVOQ (Drug) $4,542
- Humira (Biological) $2,404
- RINVOQ (Biological) $1,998
- HUMIRA (Biological) $1,263
- KRYSTEXXA (Biological) $175.75
- LUPKYNIS (Drug) $125.00
- Cimzia (Drug) $114.09
- VUITY (Drug) $113.48
- KRYSTEXXA (Drug) $109.43
- Zilretta (Drug) $99.24
- Rituxan (Biological) $73.05
- XELJANZ (Drug) $67.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Voorhees
Joshua Sundhar, Md, MD
Rheumatology — Payments: $271,886
Rheumatology $271,886
James Dwyer, Do, DO
Rheumatology — Payments: $35,199
Rheumatology $35,199
Sheldon Solomon, M.d, M.D
Rheumatology — Payments: $19,268
Rheumatology $19,268
Mugdha Agrawal, M.d, M.D
Rheumatology — Payments: $7,855
Rheumatology $7,855
Amy Evangelisto, Md, MD
Rheumatology — Payments: $3,981
Rheumatology $3,981
Humaira Hussain, Md, MD
Rheumatology — Payments: $3,198
Rheumatology $3,198